TNK2 and cancer: To date, it has been well established that miR-7 directly targets many oncogenic factors and is involved into multiple cancer-related signalling pathways, including EGFR, IRS-1/2, Raf1, Pak1, Ack1, PA28-gamma, IGF1R, PIK3CD and mTOR32–38.